Dachaigh › Luchd-obrach › Enveda Therapeutics, Inc.
Enveda Therapeutics, Inc.: Tuarastalan H-1B agus taic bhìosa
Chuir Enveda Therapeutics, Inc. 9 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 9. Tuarastal meadhanach a chaidh a thabhann: $175,100.
A bheil Enveda Therapeutics, Inc. a’ toirt taic do bhìosaichean H-1B?
Chuir Enveda Therapeutics, Inc. 9 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 17 Ògmh 2026. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Biomarker Operations Manager | 2 | $178,800 |
| Data Scientist | 1 | $120,000 |
| Sr. Manager, Business Development | 1 | $150,000 |
| Cosmetics Project Manager | 1 | $90,000 |
| Associate Vice President | 1 | $260,000 |
| Sr. Software Engineer | 1 | $185,000 |
| Senior CMC Project Manager | 1 | $140,000 |
| VP, Corporate Development | 1 | $335,000 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 1 | $120,000 |
| FY2024 | 2 | $120,000 |
| FY2025 | 2 | $222,500 |
| FY2026 | 4 | $178,800 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
- Financial Managers2
- Natural Sciences Managers2
- Molecular and Cellular Biologists1
- Management Analysts1
- Biochemists and Biophysicists1
- Software Developers1
- Regulatory Affairs Managers1
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Senior CMC Project Manager | $140,000 Ìre II | Spring, TX | 17 Ògmh 2026 | 30 Ògmh 2026 | Dearbhaichte |
| VP, Corporate Development | $335,000 Ìre IV | Boulder, CO | 17 Ògmh 2026 | 16 Dùbh 2026 | Dearbhaichte |
| Biomarker Operations Manager | $182,500 Ìre III | Lebanon, OH | 23 Gibl 2026 | 1 Dàmh 2026 | Dearbhaichte |
| Biomarker Operations Manager | $175,100 Ìre III | Lebanon, OH | 10 Gibl 2026 | 1 Dàmh 2026 | Dearbhaichte |
| Associate Vice President | $260,000–$325,000 Ìre III | San Francisco, CA | 19 Cèit 2025 | 12 Sult 2025 | Dearbhaichte |
| Sr. Software Engineer | $185,000 Ìre IV | Jersey City, NJ | 23 Gibl 2025 | 1 Dàmh 2025 | Dearbhaichte |
| Sr. Manager, Business Development | $150,000–$200,000 Ìre III | New York, NY | 12 Dàmh 2023 | 13 Samh 2023 | Dearbhaichte |
| Cosmetics Project Manager | $90,000–$120,000 Ìre II | Boulder, CO | 6 Dàmh 2023 | 6 Samh 2023 | Dearbhaichte |
| Data Scientist | $120,000–$180,000 Ìre II | Indianapolis, IN | 24 Lùna 2023 | 1 Dàmh 2023 | Dearbhaichte |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).